Portal de Periódicos da CAPES

Anterior Chamber Migration of Dexamethasone Intravitreal Implant (Ozurdex®) through Basal Iridectomy (Ando) in a Pseudophakic Patient

2015; SAGE Publishing; Volume: 26; Issue: 3 Linguagem: Inglês

10.5301/ejo.5000715

1724-6016

Alexandr Stěpanov, Marco Codenotti, A. Ramoni, Matteo Prati, N Jirásková, P Rozsíval, Francesco Bandello,

Glaucoma and retinal disorders

Purpose Intravitreal implantation of dexamethasone implant (Ozurdex®) is being widely used for the treatment of macular edema (ME) after branch or central retinal vein occlusion, diabetic ME, and persistent ME associated with uveitis or Irvine-Gass syndrome. We describe a complication: migration of the dexamethasone implant into the anterior chamber through basal iridectomy (Ando) in a pseudophakic patient with development of corneal edema and secondary high intraocular pressure. Methods This is a case report of migration of Ozurdex® through basal iridectomy in a pseudophakic patient with iris claw lens. Conclusions Pseudophakic patients, with a history of vitrectomy, even those with a basal iridectomy (Ando), are at high risk for migration of the Ozurdex® into the anterior chamber and development of corneal edema.